nodes	percent_of_prediction	percent_of_DWPC	metapath
Digoxin—CYP11A1—Cholecalciferol—psoriasis	0.125	0.147	CbGbCtD
Digoxin—SLCO4C1—Methotrexate—psoriasis	0.0652	0.0767	CbGbCtD
Digoxin—SLCO1B3—Mycophenolate mofetil—psoriasis	0.0638	0.075	CbGbCtD
Digoxin—CYP11A1—Dexamethasone—psoriasis	0.0539	0.0634	CbGbCtD
Digoxin—ABCB11—Cyclosporine—psoriasis	0.047	0.0553	CbGbCtD
Digoxin—SLCO1C1—Methotrexate—psoriasis	0.0458	0.0538	CbGbCtD
Digoxin—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0371	0.0437	CbGbCtD
Digoxin—SLCO1A2—Prednisolone—psoriasis	0.0333	0.0392	CbGbCtD
Digoxin—SLCO1A2—Hydrocortisone—psoriasis	0.0316	0.0371	CbGbCtD
Digoxin—SLCO1A2—Prednisone—psoriasis	0.0315	0.037	CbGbCtD
Digoxin—ABCB11—Dexamethasone—psoriasis	0.031	0.0364	CbGbCtD
Digoxin—SLCO1A2—Cyclosporine—psoriasis	0.0298	0.0351	CbGbCtD
Digoxin—SLCO1B1—Cyclosporine—psoriasis	0.0281	0.0331	CbGbCtD
Digoxin—SLCO1B3—Methotrexate—psoriasis	0.0256	0.0301	CbGbCtD
Digoxin—SLCO1A2—Dexamethasone—psoriasis	0.0196	0.0231	CbGbCtD
Digoxin—SLCO1A2—Methotrexate—psoriasis	0.0158	0.0186	CbGbCtD
Digoxin—SLCO1B1—Methotrexate—psoriasis	0.0149	0.0175	CbGbCtD
Digoxin—CYP3A4—Calcitriol—psoriasis	0.0143	0.0168	CbGbCtD
Digoxin—SLC22A8—Methotrexate—psoriasis	0.0138	0.0162	CbGbCtD
Digoxin—CYP3A4—Methoxsalen—psoriasis	0.0111	0.013	CbGbCtD
Digoxin—ABCB1—Mycophenolate mofetil—psoriasis	0.0106	0.0125	CbGbCtD
Digoxin—ABCB1—Betamethasone—psoriasis	0.00913	0.0107	CbGbCtD
Digoxin—ABCB1—Prednisolone—psoriasis	0.00901	0.0106	CbGbCtD
Digoxin—ABCB1—Hydrocortisone—psoriasis	0.00854	0.01	CbGbCtD
Digoxin—ABCB1—Prednisone—psoriasis	0.00851	0.01	CbGbCtD
Digoxin—ABCB1—Cyclosporine—psoriasis	0.00806	0.00948	CbGbCtD
Digoxin—CYP3A4—Cholecalciferol—psoriasis	0.00735	0.00864	CbGbCtD
Digoxin—CYP3A4—Mycophenolate mofetil—psoriasis	0.00637	0.00749	CbGbCtD
Digoxin—CYP3A4—Triamcinolone—psoriasis	0.00637	0.00749	CbGbCtD
Digoxin—CYP3A4—Betamethasone—psoriasis	0.00547	0.00643	CbGbCtD
Digoxin—CYP3A4—Prednisolone—psoriasis	0.0054	0.00634	CbGbCtD
Digoxin—ABCB1—Dexamethasone—psoriasis	0.00531	0.00624	CbGbCtD
Digoxin—CYP3A4—Hydrocortisone—psoriasis	0.00512	0.00601	CbGbCtD
Digoxin—CYP3A4—Prednisone—psoriasis	0.0051	0.00599	CbGbCtD
Digoxin—CYP3A4—Cyclosporine—psoriasis	0.00483	0.00568	CbGbCtD
Digoxin—ABCB1—Methotrexate—psoriasis	0.00427	0.00502	CbGbCtD
Digoxin—SLC51A—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.00395	0.0998	CbGpPWpGaD
Digoxin—SLC51B—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.00395	0.0998	CbGpPWpGaD
Digoxin—CYP3A4—Dexamethasone—psoriasis	0.00318	0.00374	CbGbCtD
Digoxin—ATP1A4—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.00115	0.029	CbGpPWpGaD
Digoxin—FXYD2—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.00102	0.0259	CbGpPWpGaD
Digoxin—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00093	0.0235	CbGpPWpGaD
Digoxin—ATP1B2—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000918	0.0232	CbGpPWpGaD
Digoxin—ATP1B1—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000918	0.0232	CbGpPWpGaD
Digoxin—ATP1B3—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000918	0.0232	CbGpPWpGaD
Digoxin—CYP11A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000918	0.0232	CbGpPWpGaD
Digoxin—ATP1B3—Cell surface interactions at the vascular wall—ITGAL—psoriasis	0.000805	0.0204	CbGpPWpGaD
Digoxin—ATP1B2—Cell surface interactions at the vascular wall—ITGAL—psoriasis	0.000805	0.0204	CbGpPWpGaD
Digoxin—ATP1B1—Cell surface interactions at the vascular wall—ITGAL—psoriasis	0.000805	0.0204	CbGpPWpGaD
Digoxin—CYP11A1—Corticotropin-releasing hormone—IVL—psoriasis	0.000777	0.0196	CbGpPWpGaD
Digoxin—ATP1A3—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000759	0.0192	CbGpPWpGaD
Digoxin—CYP11A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000754	0.0191	CbGpPWpGaD
Digoxin—ATP1B3—Hemostasis—SERPINB8—psoriasis	0.000752	0.019	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—SERPINB8—psoriasis	0.000752	0.019	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—SERPINB8—psoriasis	0.000752	0.019	CbGpPWpGaD
Digoxin—ABCB11—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000653	0.0165	CbGpPWpGaD
Digoxin—ATP1A3—SIDS Susceptibility Pathways—IL13—psoriasis	0.000599	0.0151	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—IL22—psoriasis	0.000564	0.0143	CbGpPWpGaD
Digoxin—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000466	0.0118	CbGpPWpGaD
Digoxin—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000433	0.0109	CbGpPWpGaD
Digoxin—Visual impairment—Mycophenolic acid—psoriasis	0.000402	0.00366	CcSEcCtD
Digoxin—CYP11A1—Biological oxidations—CYP2S1—psoriasis	0.0004	0.0101	CbGpPWpGaD
Digoxin—Abdominal pain—Calcitriol—psoriasis	0.0004	0.00365	CcSEcCtD
Digoxin—Dyspepsia—Acitretin—psoriasis	0.000397	0.00361	CcSEcCtD
Digoxin—CYP11A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000395	0.00998	CbGpPWpGaD
Digoxin—Decreased appetite—Acitretin—psoriasis	0.000392	0.00357	CcSEcCtD
Digoxin—Visual disturbance—Dexamethasone—psoriasis	0.000391	0.00356	CcSEcCtD
Digoxin—Visual disturbance—Betamethasone—psoriasis	0.000391	0.00356	CcSEcCtD
Digoxin—Gastrointestinal disorder—Acitretin—psoriasis	0.000389	0.00355	CcSEcCtD
Digoxin—Cardiac arrest—Triamcinolone—psoriasis	0.000388	0.00354	CcSEcCtD
Digoxin—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.000388	0.00354	CcSEcCtD
Digoxin—Cardiac disorder—Mycophenolic acid—psoriasis	0.000387	0.00353	CcSEcCtD
Digoxin—Dizziness—Methoxsalen—psoriasis	0.000376	0.00342	CcSEcCtD
Digoxin—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000375	0.00948	CbGpPWpGaD
Digoxin—ATP1A3—SIDS Susceptibility Pathways—IL10—psoriasis	0.000375	0.00947	CbGpPWpGaD
Digoxin—Arrhythmia—Mycophenolic acid—psoriasis	0.000372	0.0034	CcSEcCtD
Digoxin—Feeling abnormal—Acitretin—psoriasis	0.000371	0.00338	CcSEcCtD
Digoxin—Gastrointestinal pain—Acitretin—psoriasis	0.000368	0.00336	CcSEcCtD
Digoxin—Asthenia—Calcitriol—psoriasis	0.000363	0.00331	CcSEcCtD
Digoxin—Psychotic disorder—Dexamethasone—psoriasis	0.000362	0.0033	CcSEcCtD
Digoxin—Psychotic disorder—Betamethasone—psoriasis	0.000362	0.0033	CcSEcCtD
Digoxin—Rash—Methoxsalen—psoriasis	0.000358	0.00327	CcSEcCtD
Digoxin—Dermatitis—Methoxsalen—psoriasis	0.000358	0.00326	CcSEcCtD
Digoxin—Abdominal pain—Acitretin—psoriasis	0.000356	0.00325	CcSEcCtD
Digoxin—Headache—Methoxsalen—psoriasis	0.000356	0.00324	CcSEcCtD
Digoxin—Cardiac arrest—Dexamethasone—psoriasis	0.000352	0.00321	CcSEcCtD
Digoxin—Cardiac arrest—Betamethasone—psoriasis	0.000352	0.00321	CcSEcCtD
Digoxin—Diarrhoea—Calcitriol—psoriasis	0.000346	0.00316	CcSEcCtD
Digoxin—Thrombocytopenia—Hydroxyurea—psoriasis	0.000346	0.00316	CcSEcCtD
Digoxin—Vision blurred—Mycophenolic acid—psoriasis	0.000342	0.00312	CcSEcCtD
Digoxin—Nausea—Methoxsalen—psoriasis	0.000337	0.00308	CcSEcCtD
Digoxin—Anorexia—Hydroxyurea—psoriasis	0.000337	0.00307	CcSEcCtD
Digoxin—Gynaecomastia—Methotrexate—psoriasis	0.000332	0.00303	CcSEcCtD
Digoxin—Hallucination—Mycophenolate mofetil—psoriasis	0.000327	0.00298	CcSEcCtD
Digoxin—Visual impairment—Cyclosporine—psoriasis	0.000325	0.00296	CcSEcCtD
Digoxin—Asthenia—Acitretin—psoriasis	0.000323	0.00295	CcSEcCtD
Digoxin—Vomiting—Calcitriol—psoriasis	0.000322	0.00293	CcSEcCtD
Digoxin—Palpitations—Mycophenolic acid—psoriasis	0.000321	0.00292	CcSEcCtD
Digoxin—Rash—Calcitriol—psoriasis	0.000319	0.00291	CcSEcCtD
Digoxin—Dermatitis—Calcitriol—psoriasis	0.000319	0.00291	CcSEcCtD
Digoxin—Headache—Calcitriol—psoriasis	0.000317	0.00289	CcSEcCtD
Digoxin—Visual impairment—Mycophenolate mofetil—psoriasis	0.000317	0.00289	CcSEcCtD
Digoxin—Psychotic disorder—Prednisone—psoriasis	0.000315	0.00287	CcSEcCtD
Digoxin—Dyspepsia—Hydroxyurea—psoriasis	0.000311	0.00284	CcSEcCtD
Digoxin—Diarrhoea—Acitretin—psoriasis	0.000308	0.00281	CcSEcCtD
Digoxin—Anxiety—Mycophenolic acid—psoriasis	0.000308	0.00281	CcSEcCtD
Digoxin—Decreased appetite—Hydroxyurea—psoriasis	0.000307	0.0028	CcSEcCtD
Digoxin—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000307	0.0028	CcSEcCtD
Digoxin—Cardiac arrest—Prednisone—psoriasis	0.000307	0.00279	CcSEcCtD
Digoxin—Cardiac disorder—Mycophenolate mofetil—psoriasis	0.000305	0.00278	CcSEcCtD
Digoxin—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000305	0.00278	CcSEcCtD
Digoxin—Arrhythmia—Cyclosporine—psoriasis	0.000301	0.00275	CcSEcCtD
Digoxin—Nausea—Calcitriol—psoriasis	0.000301	0.00274	CcSEcCtD
Digoxin—Confusional state—Mycophenolic acid—psoriasis	0.000299	0.00272	CcSEcCtD
Digoxin—Hallucination—Hydrocortisone—psoriasis	0.000298	0.00272	CcSEcCtD
Digoxin—Dizziness—Acitretin—psoriasis	0.000298	0.00272	CcSEcCtD
Digoxin—Dizziness—Fluocinolone Acetonide—psoriasis	0.000297	0.00271	CcSEcCtD
Digoxin—Visual impairment—Prednisolone—psoriasis	0.000296	0.0027	CcSEcCtD
Digoxin—Arrhythmia—Mycophenolate mofetil—psoriasis	0.000294	0.00268	CcSEcCtD
Digoxin—Feeling abnormal—Hydroxyurea—psoriasis	0.000291	0.00266	CcSEcCtD
Digoxin—Thrombocytopenia—Mycophenolic acid—psoriasis	0.00029	0.00264	CcSEcCtD
Digoxin—SLCO4A1—SLC-mediated transmembrane transport—CP—psoriasis	0.00029	0.00732	CbGpPWpGaD
Digoxin—SLCO4C1—SLC-mediated transmembrane transport—CP—psoriasis	0.00029	0.00732	CbGpPWpGaD
Digoxin—Tachycardia—Mycophenolic acid—psoriasis	0.000289	0.00264	CcSEcCtD
Digoxin—Vomiting—Acitretin—psoriasis	0.000286	0.00261	CcSEcCtD
Digoxin—Vomiting—Fluocinolone Acetonide—psoriasis	0.000286	0.0026	CcSEcCtD
Digoxin—Visual disturbance—Methotrexate—psoriasis	0.000284	0.00259	CcSEcCtD
Digoxin—Rash—Acitretin—psoriasis	0.000284	0.00259	CcSEcCtD
Digoxin—Dermatitis—Acitretin—psoriasis	0.000284	0.00259	CcSEcCtD
Digoxin—Rash—Fluocinolone Acetonide—psoriasis	0.000283	0.00258	CcSEcCtD
Digoxin—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000283	0.00258	CcSEcCtD
Digoxin—Anorexia—Mycophenolic acid—psoriasis	0.000282	0.00257	CcSEcCtD
Digoxin—Headache—Acitretin—psoriasis	0.000282	0.00257	CcSEcCtD
Digoxin—Headache—Fluocinolone Acetonide—psoriasis	0.000281	0.00257	CcSEcCtD
Digoxin—Vision blurred—Cyclosporine—psoriasis	0.000277	0.00252	CcSEcCtD
Digoxin—Arrhythmia—Prednisolone—psoriasis	0.000274	0.0025	CcSEcCtD
Digoxin—Arrhythmia—Hydrocortisone—psoriasis	0.000268	0.00244	CcSEcCtD
Digoxin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000268	0.00676	CbGpPWpGaD
Digoxin—Nausea—Acitretin—psoriasis	0.000268	0.00244	CcSEcCtD
Digoxin—Nausea—Fluocinolone Acetonide—psoriasis	0.000267	0.00243	CcSEcCtD
Digoxin—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000261	0.00661	CbGpPWpGaD
Digoxin—Dyspepsia—Mycophenolic acid—psoriasis	0.000261	0.00238	CcSEcCtD
Digoxin—Decreased appetite—Mycophenolic acid—psoriasis	0.000257	0.00235	CcSEcCtD
Digoxin—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000256	0.00233	CcSEcCtD
Digoxin—Hallucination—Betamethasone—psoriasis	0.000255	0.00232	CcSEcCtD
Digoxin—Hallucination—Dexamethasone—psoriasis	0.000255	0.00232	CcSEcCtD
Digoxin—Asthenia—Hydroxyurea—psoriasis	0.000254	0.00231	CcSEcCtD
Digoxin—Palpitations—Mycophenolate mofetil—psoriasis	0.000253	0.00231	CcSEcCtD
Digoxin—Arrhythmia—Triamcinolone—psoriasis	0.000252	0.0023	CcSEcCtD
Digoxin—Vision blurred—Prednisolone—psoriasis	0.000252	0.0023	CcSEcCtD
Digoxin—Anxiety—Cyclosporine—psoriasis	0.000249	0.00227	CcSEcCtD
Digoxin—Visual impairment—Dexamethasone—psoriasis	0.000247	0.00225	CcSEcCtD
Digoxin—Visual impairment—Betamethasone—psoriasis	0.000247	0.00225	CcSEcCtD
Digoxin—Feeling abnormal—Mycophenolic acid—psoriasis	0.000244	0.00223	CcSEcCtD
Digoxin—Anxiety—Mycophenolate mofetil—psoriasis	0.000243	0.00222	CcSEcCtD
Digoxin—SLCO1C1—SLC-mediated transmembrane transport—CP—psoriasis	0.000243	0.00613	CbGpPWpGaD
Digoxin—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000242	0.00221	CcSEcCtD
Digoxin—Diarrhoea—Hydroxyurea—psoriasis	0.000242	0.00221	CcSEcCtD
Digoxin—Confusional state—Cyclosporine—psoriasis	0.000242	0.0022	CcSEcCtD
Digoxin—Confusional state—Mycophenolate mofetil—psoriasis	0.000236	0.00215	CcSEcCtD
Digoxin—Thrombocytopenia—Cyclosporine—psoriasis	0.000235	0.00214	CcSEcCtD
Digoxin—Abdominal pain—Mycophenolic acid—psoriasis	0.000234	0.00213	CcSEcCtD
Digoxin—Dizziness—Hydroxyurea—psoriasis	0.000234	0.00213	CcSEcCtD
Digoxin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000233	0.0059	CbGpPWpGaD
Digoxin—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000229	0.00209	CcSEcCtD
Digoxin—Arrhythmia—Betamethasone—psoriasis	0.000229	0.00209	CcSEcCtD
Digoxin—Arrhythmia—Dexamethasone—psoriasis	0.000229	0.00209	CcSEcCtD
Digoxin—Anorexia—Cyclosporine—psoriasis	0.000228	0.00208	CcSEcCtD
Digoxin—ATP1A3—Transmembrane transport of small molecules—CP—psoriasis	0.000228	0.00577	CbGpPWpGaD
Digoxin—ATP1A2—Transmembrane transport of small molecules—CP—psoriasis	0.000228	0.00577	CbGpPWpGaD
Digoxin—ATP1A4—Transmembrane transport of small molecules—CP—psoriasis	0.000228	0.00577	CbGpPWpGaD
Digoxin—Tachycardia—Mycophenolate mofetil—psoriasis	0.000228	0.00208	CcSEcCtD
Digoxin—Vomiting—Hydroxyurea—psoriasis	0.000225	0.00205	CcSEcCtD
Digoxin—Rash—Hydroxyurea—psoriasis	0.000223	0.00203	CcSEcCtD
Digoxin—Anorexia—Mycophenolate mofetil—psoriasis	0.000223	0.00203	CcSEcCtD
Digoxin—Dermatitis—Hydroxyurea—psoriasis	0.000223	0.00203	CcSEcCtD
Digoxin—Hallucination—Prednisone—psoriasis	0.000222	0.00202	CcSEcCtD
Digoxin—Headache—Hydroxyurea—psoriasis	0.000222	0.00202	CcSEcCtD
Digoxin—Anxiety—Hydrocortisone—psoriasis	0.000221	0.00202	CcSEcCtD
Digoxin—ATP1B1—Hemostasis—ITGAL—psoriasis	0.000218	0.00552	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—ITGAL—psoriasis	0.000218	0.00552	CbGpPWpGaD
Digoxin—ATP1B3—Hemostasis—ITGAL—psoriasis	0.000218	0.00552	CbGpPWpGaD
Digoxin—ATP1A4—Transmembrane transport of small molecules—CARM1—psoriasis	0.000218	0.00551	CbGpPWpGaD
Digoxin—ATP1A2—Transmembrane transport of small molecules—CARM1—psoriasis	0.000218	0.00551	CbGpPWpGaD
Digoxin—ATP1A3—Transmembrane transport of small molecules—CARM1—psoriasis	0.000218	0.00551	CbGpPWpGaD
Digoxin—Tachycardia—Prednisolone—psoriasis	0.000213	0.00194	CcSEcCtD
Digoxin—Asthenia—Mycophenolic acid—psoriasis	0.000213	0.00194	CcSEcCtD
Digoxin—Dyspepsia—Cyclosporine—psoriasis	0.000211	0.00192	CcSEcCtD
Digoxin—Nausea—Hydroxyurea—psoriasis	0.00021	0.00191	CcSEcCtD
Digoxin—Decreased appetite—Cyclosporine—psoriasis	0.000208	0.0019	CcSEcCtD
Digoxin—Tachycardia—Hydrocortisone—psoriasis	0.000208	0.00189	CcSEcCtD
Digoxin—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000207	0.00189	CcSEcCtD
Digoxin—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000206	0.00188	CcSEcCtD
Digoxin—ATP1A3—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000205	0.00518	CbGpPWpGaD
Digoxin—FXYD2—Transmembrane transport of small molecules—CP—psoriasis	0.000203	0.00514	CbGpPWpGaD
Digoxin—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000203	0.00185	CcSEcCtD
Digoxin—Anorexia—Hydrocortisone—psoriasis	0.000203	0.00185	CcSEcCtD
Digoxin—Diarrhoea—Mycophenolic acid—psoriasis	0.000203	0.00185	CcSEcCtD
Digoxin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000202	0.00184	CcSEcCtD
Digoxin—Arrhythmia—Prednisone—psoriasis	0.000199	0.00182	CcSEcCtD
Digoxin—Feeling abnormal—Cyclosporine—psoriasis	0.000197	0.0018	CcSEcCtD
Digoxin—Gastrointestinal pain—Cyclosporine—psoriasis	0.000196	0.00179	CcSEcCtD
Digoxin—Dizziness—Mycophenolic acid—psoriasis	0.000196	0.00179	CcSEcCtD
Digoxin—Tachycardia—Triamcinolone—psoriasis	0.000196	0.00178	CcSEcCtD
Digoxin—FXYD2—Transmembrane transport of small molecules—CARM1—psoriasis	0.000194	0.00491	CbGpPWpGaD
Digoxin—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000193	0.00176	CcSEcCtD
Digoxin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000191	0.00174	CcSEcCtD
Digoxin—ATP1A3—SIDS Susceptibility Pathways—JUN—psoriasis	0.00019	0.00481	CbGpPWpGaD
Digoxin—Abdominal pain—Cyclosporine—psoriasis	0.000189	0.00173	CcSEcCtD
Digoxin—Anxiety—Dexamethasone—psoriasis	0.000189	0.00172	CcSEcCtD
Digoxin—Anxiety—Betamethasone—psoriasis	0.000189	0.00172	CcSEcCtD
Digoxin—Vomiting—Mycophenolic acid—psoriasis	0.000188	0.00172	CcSEcCtD
Digoxin—Dyspepsia—Hydrocortisone—psoriasis	0.000187	0.00171	CcSEcCtD
Digoxin—Rash—Mycophenolic acid—psoriasis	0.000187	0.0017	CcSEcCtD
Digoxin—Dermatitis—Mycophenolic acid—psoriasis	0.000187	0.0017	CcSEcCtD
Digoxin—Headache—Mycophenolic acid—psoriasis	0.000186	0.00169	CcSEcCtD
Digoxin—Decreased appetite—Hydrocortisone—psoriasis	0.000185	0.00169	CcSEcCtD
Digoxin—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000185	0.00168	CcSEcCtD
Digoxin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000184	0.00168	CcSEcCtD
Digoxin—ATP1A3—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000183	0.00463	CbGpPWpGaD
Digoxin—Vision blurred—Prednisone—psoriasis	0.000183	0.00167	CcSEcCtD
Digoxin—ATP1B1—Transmembrane transport of small molecules—CP—psoriasis	0.000183	0.00461	CbGpPWpGaD
Digoxin—ATP1B3—Transmembrane transport of small molecules—CP—psoriasis	0.000183	0.00461	CbGpPWpGaD
Digoxin—ATP1B2—Transmembrane transport of small molecules—CP—psoriasis	0.000183	0.00461	CbGpPWpGaD
Digoxin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00018	0.00454	CbGpPWpGaD
Digoxin—Feeling abnormal—Prednisolone—psoriasis	0.00018	0.00164	CcSEcCtD
Digoxin—Visual impairment—Methotrexate—psoriasis	0.00018	0.00164	CcSEcCtD
Digoxin—Thrombocytopenia—Betamethasone—psoriasis	0.000178	0.00162	CcSEcCtD
Digoxin—Thrombocytopenia—Dexamethasone—psoriasis	0.000178	0.00162	CcSEcCtD
Digoxin—Tachycardia—Betamethasone—psoriasis	0.000178	0.00162	CcSEcCtD
Digoxin—Tachycardia—Dexamethasone—psoriasis	0.000178	0.00162	CcSEcCtD
Digoxin—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000177	0.00448	CbGpPWpGaD
Digoxin—Dyspepsia—Triamcinolone—psoriasis	0.000177	0.00161	CcSEcCtD
Digoxin—SLCO2B1—SLC-mediated transmembrane transport—CP—psoriasis	0.000176	0.00445	CbGpPWpGaD
Digoxin—Nausea—Mycophenolic acid—psoriasis	0.000176	0.0016	CcSEcCtD
Digoxin—Feeling abnormal—Hydrocortisone—psoriasis	0.000175	0.0016	CcSEcCtD
Digoxin—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000174	0.00159	CcSEcCtD
Digoxin—ATP1B1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000174	0.0044	CbGpPWpGaD
Digoxin—ATP1B3—Transmembrane transport of small molecules—CARM1—psoriasis	0.000174	0.0044	CbGpPWpGaD
Digoxin—ATP1B2—Transmembrane transport of small molecules—CARM1—psoriasis	0.000174	0.0044	CbGpPWpGaD
Digoxin—Anorexia—Dexamethasone—psoriasis	0.000173	0.00158	CcSEcCtD
Digoxin—Anorexia—Betamethasone—psoriasis	0.000173	0.00158	CcSEcCtD
Digoxin—Cardiac disorder—Methotrexate—psoriasis	0.000173	0.00158	CcSEcCtD
Digoxin—Asthenia—Cyclosporine—psoriasis	0.000172	0.00157	CcSEcCtD
Digoxin—Abdominal pain—Hydrocortisone—psoriasis	0.000168	0.00153	CcSEcCtD
Digoxin—Asthenia—Mycophenolate mofetil—psoriasis	0.000168	0.00153	CcSEcCtD
Digoxin—ATP1A3—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000166	0.00421	CbGpPWpGaD
Digoxin—Feeling abnormal—Triamcinolone—psoriasis	0.000165	0.00151	CcSEcCtD
Digoxin—Anxiety—Prednisone—psoriasis	0.000165	0.0015	CcSEcCtD
Digoxin—Diarrhoea—Cyclosporine—psoriasis	0.000164	0.00149	CcSEcCtD
Digoxin—Dyspepsia—Betamethasone—psoriasis	0.00016	0.00146	CcSEcCtD
Digoxin—Dyspepsia—Dexamethasone—psoriasis	0.00016	0.00146	CcSEcCtD
Digoxin—Diarrhoea—Mycophenolate mofetil—psoriasis	0.00016	0.00146	CcSEcCtD
Digoxin—Dizziness—Cyclosporine—psoriasis	0.000158	0.00144	CcSEcCtD
Digoxin—Decreased appetite—Dexamethasone—psoriasis	0.000158	0.00144	CcSEcCtD
Digoxin—Decreased appetite—Betamethasone—psoriasis	0.000158	0.00144	CcSEcCtD
Digoxin—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000157	0.00143	CcSEcCtD
Digoxin—Gastrointestinal disorder—Betamethasone—psoriasis	0.000157	0.00143	CcSEcCtD
Digoxin—Tachycardia—Prednisone—psoriasis	0.000155	0.00141	CcSEcCtD
Digoxin—Dizziness—Mycophenolate mofetil—psoriasis	0.000155	0.00141	CcSEcCtD
Digoxin—Vision blurred—Methotrexate—psoriasis	0.000153	0.00139	CcSEcCtD
Digoxin—Asthenia—Hydrocortisone—psoriasis	0.000153	0.00139	CcSEcCtD
Digoxin—Vomiting—Cyclosporine—psoriasis	0.000152	0.00139	CcSEcCtD
Digoxin—Rash—Cyclosporine—psoriasis	0.000151	0.00138	CcSEcCtD
Digoxin—Anorexia—Prednisone—psoriasis	0.000151	0.00138	CcSEcCtD
Digoxin—Dermatitis—Cyclosporine—psoriasis	0.000151	0.00138	CcSEcCtD
Digoxin—Headache—Cyclosporine—psoriasis	0.00015	0.00137	CcSEcCtD
Digoxin—Feeling abnormal—Betamethasone—psoriasis	0.00015	0.00137	CcSEcCtD
Digoxin—Feeling abnormal—Dexamethasone—psoriasis	0.00015	0.00137	CcSEcCtD
Digoxin—Gastrointestinal pain—Betamethasone—psoriasis	0.000149	0.00136	CcSEcCtD
Digoxin—Gastrointestinal pain—Dexamethasone—psoriasis	0.000149	0.00136	CcSEcCtD
Digoxin—Vomiting—Mycophenolate mofetil—psoriasis	0.000149	0.00135	CcSEcCtD
Digoxin—Rash—Mycophenolate mofetil—psoriasis	0.000147	0.00134	CcSEcCtD
Digoxin—Dermatitis—Mycophenolate mofetil—psoriasis	0.000147	0.00134	CcSEcCtD
Digoxin—SLCO4C1—Transmembrane transport of small molecules—CP—psoriasis	0.000147	0.00372	CbGpPWpGaD
Digoxin—SLCO4A1—Transmembrane transport of small molecules—CP—psoriasis	0.000147	0.00372	CbGpPWpGaD
Digoxin—Headache—Mycophenolate mofetil—psoriasis	0.000146	0.00133	CcSEcCtD
Digoxin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000146	0.00368	CbGpPWpGaD
Digoxin—Diarrhoea—Hydrocortisone—psoriasis	0.000146	0.00133	CcSEcCtD
Digoxin—Dizziness—Prednisolone—psoriasis	0.000144	0.00131	CcSEcCtD
Digoxin—Asthenia—Triamcinolone—psoriasis	0.000144	0.00131	CcSEcCtD
Digoxin—Abdominal pain—Betamethasone—psoriasis	0.000144	0.00131	CcSEcCtD
Digoxin—Abdominal pain—Dexamethasone—psoriasis	0.000144	0.00131	CcSEcCtD
Digoxin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000144	0.00363	CbGpPWpGaD
Digoxin—CYP11A1—Corticotropin-releasing hormone—NFKBIA—psoriasis	0.000144	0.00363	CbGpPWpGaD
Digoxin—ATP1A3—SIDS Susceptibility Pathways—TNF—psoriasis	0.000143	0.0036	CbGpPWpGaD
Digoxin—Nausea—Cyclosporine—psoriasis	0.000142	0.0013	CcSEcCtD
Digoxin—Dizziness—Hydrocortisone—psoriasis	0.000141	0.00128	CcSEcCtD
Digoxin—SLCO4C1—Transmembrane transport of small molecules—CARM1—psoriasis	0.00014	0.00355	CbGpPWpGaD
Digoxin—SLCO4A1—Transmembrane transport of small molecules—CARM1—psoriasis	0.00014	0.00355	CbGpPWpGaD
Digoxin—Dyspepsia—Prednisone—psoriasis	0.000139	0.00127	CcSEcCtD
Digoxin—Nausea—Mycophenolate mofetil—psoriasis	0.000139	0.00127	CcSEcCtD
Digoxin—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000138	0.0035	CbGpPWpGaD
Digoxin—Decreased appetite—Prednisone—psoriasis	0.000138	0.00126	CcSEcCtD
Digoxin—Rash—Prednisolone—psoriasis	0.000137	0.00125	CcSEcCtD
Digoxin—SLCO1B3—SLC-mediated transmembrane transport—CP—psoriasis	0.000137	0.00347	CbGpPWpGaD
Digoxin—Dermatitis—Prednisolone—psoriasis	0.000137	0.00125	CcSEcCtD
Digoxin—Headache—Prednisolone—psoriasis	0.000137	0.00125	CcSEcCtD
Digoxin—Vomiting—Hydrocortisone—psoriasis	0.000135	0.00123	CcSEcCtD
Digoxin—Rash—Hydrocortisone—psoriasis	0.000134	0.00122	CcSEcCtD
Digoxin—Dermatitis—Hydrocortisone—psoriasis	0.000134	0.00122	CcSEcCtD
Digoxin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000134	0.00339	CbGpPWpGaD
Digoxin—Confusional state—Methotrexate—psoriasis	0.000134	0.00122	CcSEcCtD
Digoxin—Headache—Hydrocortisone—psoriasis	0.000133	0.00122	CcSEcCtD
Digoxin—Dizziness—Triamcinolone—psoriasis	0.000133	0.00121	CcSEcCtD
Digoxin—Feeling abnormal—Prednisone—psoriasis	0.000131	0.00119	CcSEcCtD
Digoxin—Asthenia—Dexamethasone—psoriasis	0.000131	0.00119	CcSEcCtD
Digoxin—Asthenia—Betamethasone—psoriasis	0.000131	0.00119	CcSEcCtD
Digoxin—Thrombocytopenia—Methotrexate—psoriasis	0.00013	0.00118	CcSEcCtD
Digoxin—Gastrointestinal pain—Prednisone—psoriasis	0.00013	0.00118	CcSEcCtD
Digoxin—Nausea—Prednisolone—psoriasis	0.00013	0.00118	CcSEcCtD
Digoxin—Vomiting—Triamcinolone—psoriasis	0.000127	0.00116	CcSEcCtD
Digoxin—Nausea—Hydrocortisone—psoriasis	0.000126	0.00115	CcSEcCtD
Digoxin—Rash—Triamcinolone—psoriasis	0.000126	0.00115	CcSEcCtD
Digoxin—Dermatitis—Triamcinolone—psoriasis	0.000126	0.00115	CcSEcCtD
Digoxin—Anorexia—Methotrexate—psoriasis	0.000126	0.00115	CcSEcCtD
Digoxin—Headache—Triamcinolone—psoriasis	0.000126	0.00115	CcSEcCtD
Digoxin—Abdominal pain—Prednisone—psoriasis	0.000125	0.00114	CcSEcCtD
Digoxin—Diarrhoea—Dexamethasone—psoriasis	0.000124	0.00113	CcSEcCtD
Digoxin—Diarrhoea—Betamethasone—psoriasis	0.000124	0.00113	CcSEcCtD
Digoxin—SLCO1C1—Transmembrane transport of small molecules—CP—psoriasis	0.000123	0.00312	CbGpPWpGaD
Digoxin—ATP1A1—Transmembrane transport of small molecules—CP—psoriasis	0.000123	0.00312	CbGpPWpGaD
Digoxin—SLC22A8—SLC-mediated transmembrane transport—CP—psoriasis	0.000122	0.00307	CbGpPWpGaD
Digoxin—Dizziness—Dexamethasone—psoriasis	0.00012	0.0011	CcSEcCtD
Digoxin—Dizziness—Betamethasone—psoriasis	0.00012	0.0011	CcSEcCtD
Digoxin—Nausea—Triamcinolone—psoriasis	0.000119	0.00109	CcSEcCtD
Digoxin—SLCO1C1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000118	0.00297	CbGpPWpGaD
Digoxin—ATP1A1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000118	0.00297	CbGpPWpGaD
Digoxin—Dyspepsia—Methotrexate—psoriasis	0.000117	0.00106	CcSEcCtD
Digoxin—Vomiting—Dexamethasone—psoriasis	0.000116	0.00105	CcSEcCtD
Digoxin—Vomiting—Betamethasone—psoriasis	0.000116	0.00105	CcSEcCtD
Digoxin—Decreased appetite—Methotrexate—psoriasis	0.000115	0.00105	CcSEcCtD
Digoxin—ATP1A3—SIDS Susceptibility Pathways—IL6—psoriasis	0.000115	0.00291	CbGpPWpGaD
Digoxin—Rash—Dexamethasone—psoriasis	0.000115	0.00105	CcSEcCtD
Digoxin—Rash—Betamethasone—psoriasis	0.000115	0.00105	CcSEcCtD
Digoxin—Dermatitis—Betamethasone—psoriasis	0.000115	0.00104	CcSEcCtD
Digoxin—Dermatitis—Dexamethasone—psoriasis	0.000115	0.00104	CcSEcCtD
Digoxin—Gastrointestinal disorder—Methotrexate—psoriasis	0.000114	0.00104	CcSEcCtD
Digoxin—Headache—Dexamethasone—psoriasis	0.000114	0.00104	CcSEcCtD
Digoxin—Headache—Betamethasone—psoriasis	0.000114	0.00104	CcSEcCtD
Digoxin—Asthenia—Prednisone—psoriasis	0.000114	0.00104	CcSEcCtD
Digoxin—Feeling abnormal—Methotrexate—psoriasis	0.000109	0.000995	CcSEcCtD
Digoxin—Diarrhoea—Prednisone—psoriasis	0.000108	0.000988	CcSEcCtD
Digoxin—Gastrointestinal pain—Methotrexate—psoriasis	0.000108	0.000987	CcSEcCtD
Digoxin—Nausea—Dexamethasone—psoriasis	0.000108	0.000985	CcSEcCtD
Digoxin—Nausea—Betamethasone—psoriasis	0.000108	0.000985	CcSEcCtD
Digoxin—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000108	0.00273	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000107	0.0027	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—IL13—psoriasis	0.000106	0.00268	CbGpPWpGaD
Digoxin—Dizziness—Prednisone—psoriasis	0.000105	0.000955	CcSEcCtD
Digoxin—Abdominal pain—Methotrexate—psoriasis	0.000105	0.000954	CcSEcCtD
Digoxin—CYP11A1—Corticotropin-releasing hormone—CXCL8—psoriasis	0.000102	0.00259	CbGpPWpGaD
Digoxin—Vomiting—Prednisone—psoriasis	0.000101	0.000918	CcSEcCtD
Digoxin—Rash—Prednisone—psoriasis	9.99e-05	0.000911	CcSEcCtD
Digoxin—Dermatitis—Prednisone—psoriasis	9.98e-05	0.00091	CcSEcCtD
Digoxin—Headache—Prednisone—psoriasis	9.93e-05	0.000905	CcSEcCtD
Digoxin—ABCB1—Allograft Rejection—IL17A—psoriasis	9.77e-05	0.00247	CbGpPWpGaD
Digoxin—Asthenia—Methotrexate—psoriasis	9.5e-05	0.000866	CcSEcCtD
Digoxin—Nausea—Prednisone—psoriasis	9.41e-05	0.000858	CcSEcCtD
Digoxin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.34e-05	0.00236	CbGpPWpGaD
Digoxin—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	9.23e-05	0.00233	CbGpPWpGaD
Digoxin—CYP11A1—Corticotropin-releasing hormone—NFKB1—psoriasis	9.17e-05	0.00232	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—IL12B—psoriasis	9.08e-05	0.0023	CbGpPWpGaD
Digoxin—Diarrhoea—Methotrexate—psoriasis	9.06e-05	0.000826	CcSEcCtD
Digoxin—ATP1B3—Hemostasis—NOS2—psoriasis	8.96e-05	0.00226	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—NOS2—psoriasis	8.96e-05	0.00226	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—NOS2—psoriasis	8.96e-05	0.00226	CbGpPWpGaD
Digoxin—SLCO2B1—Transmembrane transport of small molecules—CP—psoriasis	8.94e-05	0.00226	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—HLA-E—psoriasis	8.87e-05	0.00224	CbGpPWpGaD
Digoxin—Dizziness—Methotrexate—psoriasis	8.76e-05	0.000798	CcSEcCtD
Digoxin—SLCO2B1—Transmembrane transport of small molecules—CARM1—psoriasis	8.53e-05	0.00216	CbGpPWpGaD
Digoxin—Vomiting—Methotrexate—psoriasis	8.42e-05	0.000768	CcSEcCtD
Digoxin—Rash—Methotrexate—psoriasis	8.35e-05	0.000761	CcSEcCtD
Digoxin—Dermatitis—Methotrexate—psoriasis	8.34e-05	0.00076	CcSEcCtD
Digoxin—Headache—Methotrexate—psoriasis	8.3e-05	0.000756	CcSEcCtD
Digoxin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.26e-05	0.00209	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—NDUFA5—psoriasis	8.05e-05	0.00204	CbGpPWpGaD
Digoxin—Nausea—Methotrexate—psoriasis	7.87e-05	0.000717	CcSEcCtD
Digoxin—CYP3A4—Biological oxidations—CYP2S1—psoriasis	7.74e-05	0.00196	CbGpPWpGaD
Digoxin—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	7.63e-05	0.00193	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—NDUFA5—psoriasis	7.51e-05	0.0019	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.51e-05	0.0019	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.34e-05	0.00185	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—NDUFA5—psoriasis	7.07e-05	0.00179	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.01e-05	0.00177	CbGpPWpGaD
Digoxin—SLCO1B3—Transmembrane transport of small molecules—CP—psoriasis	6.98e-05	0.00176	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—CYP2S1—psoriasis	6.85e-05	0.00173	CbGpPWpGaD
Digoxin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.68e-05	0.00169	CbGpPWpGaD
Digoxin—SLCO1B3—Transmembrane transport of small molecules—CARM1—psoriasis	6.66e-05	0.00168	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—IL10—psoriasis	6.64e-05	0.00168	CbGpPWpGaD
Digoxin—ABCB11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.59e-05	0.00167	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—IL4—psoriasis	6.46e-05	0.00163	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—CYP2S1—psoriasis	6.39e-05	0.00161	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.32e-05	0.0016	CbGpPWpGaD
Digoxin—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.31e-05	0.00159	CbGpPWpGaD
Digoxin—SLC22A8—Transmembrane transport of small molecules—CP—psoriasis	6.18e-05	0.00156	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—CYP2S1—psoriasis	6.01e-05	0.00152	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—NDUFA5—psoriasis	5.9e-05	0.00149	CbGpPWpGaD
Digoxin—SLC22A8—Transmembrane transport of small molecules—CARM1—psoriasis	5.89e-05	0.00149	CbGpPWpGaD
Digoxin—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.88e-05	0.00149	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.85e-05	0.00148	CbGpPWpGaD
Digoxin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.76e-05	0.00146	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.5e-05	0.00139	CbGpPWpGaD
Digoxin—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	5.49e-05	0.00139	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.35e-05	0.00135	CbGpPWpGaD
Digoxin—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	5.23e-05	0.00132	CbGpPWpGaD
Digoxin—ATP1B3—Hemostasis—VEGFA—psoriasis	5.19e-05	0.00131	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—VEGFA—psoriasis	5.19e-05	0.00131	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—VEGFA—psoriasis	5.19e-05	0.00131	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—NDUFA5—psoriasis	5.05e-05	0.00128	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—CYP2S1—psoriasis	5.02e-05	0.00127	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.71e-05	0.00119	CbGpPWpGaD
Digoxin—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	4.69e-05	0.00119	CbGpPWpGaD
Digoxin—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	4.48e-05	0.00113	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—CYP2S1—psoriasis	4.29e-05	0.00108	CbGpPWpGaD
Digoxin—ATP1B3—Hemostasis—TP53—psoriasis	3.92e-05	0.000991	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—TP53—psoriasis	3.92e-05	0.000991	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—TP53—psoriasis	3.92e-05	0.000991	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—IFNG—psoriasis	3.91e-05	0.000987	CbGpPWpGaD
Digoxin—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.9e-05	0.000985	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.63e-05	0.000918	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.59e-05	0.000907	CbGpPWpGaD
Digoxin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.41e-05	0.000861	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.35e-05	0.000846	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—CARM1—psoriasis	3.34e-05	0.000845	CbGpPWpGaD
Digoxin—ABCB11—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.15e-05	0.000796	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.13e-05	0.00079	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—CARM1—psoriasis	3.12e-05	0.000789	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.99e-05	0.000756	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.95e-05	0.000745	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—CARM1—psoriasis	2.94e-05	0.000742	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.92e-05	0.000737	CbGpPWpGaD
Digoxin—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.74e-05	0.000694	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.63e-05	0.000665	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—TNF—psoriasis	2.53e-05	0.000639	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—NDUFA5—psoriasis	2.53e-05	0.000639	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.51e-05	0.000635	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—CARM1—psoriasis	2.45e-05	0.00062	CbGpPWpGaD
Digoxin—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.35e-05	0.000594	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.29e-05	0.000579	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.25e-05	0.000569	CbGpPWpGaD
Digoxin—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.24e-05	0.000566	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—CYP2S1—psoriasis	2.15e-05	0.000543	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—CARM1—psoriasis	2.1e-05	0.00053	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—CAT—psoriasis	2.06e-05	0.00052	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.96e-05	0.000495	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—CAT—psoriasis	1.92e-05	0.000485	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—CAT—psoriasis	1.81e-05	0.000456	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.67e-05	0.000421	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.6e-05	0.000405	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—APOE—psoriasis	1.6e-05	0.000404	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—NDUFA5—psoriasis	1.56e-05	0.000394	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—CAT—psoriasis	1.51e-05	0.000381	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—APOE—psoriasis	1.49e-05	0.000377	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.46e-05	0.000368	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—APOE—psoriasis	1.4e-05	0.000355	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—PPARG—psoriasis	1.39e-05	0.000352	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—CYP2S1—psoriasis	1.32e-05	0.000335	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—PPARG—psoriasis	1.3e-05	0.000328	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—CAT—psoriasis	1.29e-05	0.000326	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.25e-05	0.000315	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—PPARG—psoriasis	1.22e-05	0.000309	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—APOE—psoriasis	1.17e-05	0.000296	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.1e-05	0.000278	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—CARM1—psoriasis	1.05e-05	0.000265	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—PPARG—psoriasis	1.02e-05	0.000258	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—APOE—psoriasis	1e-05	0.000253	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—PPARG—psoriasis	8.73e-06	0.000221	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—CARM1—psoriasis	6.47e-06	0.000163	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—CAT—psoriasis	6.45e-06	0.000163	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—APOE—psoriasis	5.02e-06	0.000127	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—PPARG—psoriasis	4.37e-06	0.00011	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—CAT—psoriasis	3.98e-06	0.000101	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—APOE—psoriasis	3.09e-06	7.81e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—PPARG—psoriasis	2.69e-06	6.8e-05	CbGpPWpGaD
